Chapters
Transcript
Benjamin Segal, MD, explains the importance of developing new drug therapy agents that will stop disability accumulation among patients with progressive multiple sclerosis.
Related Presenters
Benjamin Segal, MD
NeurologyProfessor and Chair of the Department of Neurology
View full profile
Related Videos
Recent Discoveries in the Pathological Features of MS
Recent Trends in the Epidemiology of MS
Disease Modifying Therapy in Progressive MS
Treatment of Relapsing Remitting MS/Disease Modifying Therapies: Efficacy and Side Effects
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account
